IDO2 and Crohn disease: In Crohn's disease and ulcerative colitis, increased expression of indoleamine 2,3-dioxygenase is associated with gastrointestinal dysfunction [42] and in irritable bowel syndrome, a simultaneous reduction of kynurenic acid and 5-HT in the duodenal mucosa is observed [43, 44].